Viemed Healthcare (VMD) EPS (Basic) (2018 - 2026)

Viemed Healthcare (VMD) has reported EPS (Basic) for 9 consecutive years, with $0.08 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) fell 7.81% year-over-year to $0.08; the trailing twelve-month figure through Jun 2026 stood at $0.39 (up 8.51% YoY), and the FY2025 full-year result was $0.4, up 34.28% from the prior year.
• EPS (Basic) improved to $0.08 in Q2 2026 per VMD's latest filing, from $0.07 in the prior quarter.
• Across five years, EPS (Basic) topped out at $0.15 in Q4 2025 and bottomed at $0.02 in Q2 2022.
• Historically, EPS (Basic) has averaged $0.07 across 5 years, with a median of $0.07 in 2026.
• The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 39.06% in 2022, then soared 175.2% in 2023.
• Over 5 years, EPS (Basic) stood at $0.06 in 2022, then jumped by 43.74% to $0.09 in 2023, then grew by 25.92% to $0.11 in 2024, then jumped by 30.99% to $0.15 in 2025, then sank by 49.29% to $0.08 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $0.08, $0.07, and $0.15 for Q2 2026, Q1 2026, and Q4 2025 respectively.